Hagit Binder
CIK: 0002118272
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NRSN
NeuroSense Therapeutics Ltd.
Officer
Discretionary Trading P&L
Holdings
About Binder Hagit
Binder Hagit (SEC CIK 0002118272) files insider reports with the SEC as General Manager of NeuroSense Therapeutics Ltd. (NRSN).
Signal8 holds 2 ownership filings by Binder Hagit (1 Form 3, 1 Form 4), filed between Mar 18, 2026 and Mar 30, 2026. Those filings report 1 transaction, the latest on Mar 26, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Binder Hagit's filings is in HERZLIYA.
Recent filings by Binder Hagit
- Mar 26, 2026: Grant or award of NRSN shares (Form 4, code A).
Other insiders filing for NeuroSense Therapeutics Ltd. (NRSN)
- Eisenberg Or, Chief Financial Officer
- Ben-Noon Alon, Chief Executive Officer
- Russek-Blum Niva, Chief Technology Officer
- Pellizzari Christine A, Director
- Tracik Ferenc, Chief Medical Officer
- Claiborne Cary J, Director